SecProbe.io

CORRESP
1
filename1.htm

Hanryu Holdings, Inc.

160, Yeouiseo-ro

Yeongdeungpo-gu, Seoul

Republic of Korea 07231

March 30, 2023

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Technology

100 F. Street, N.W.

Mail Stop 6010/3561

Washington, DC 20549

    Attention:
    Melissa
    Kindelan, Senior Staff Accountant

Kathleen Collins, Accounting
Branch Chief

Larry Spirgel, Office Chief

Edwin Kim, Staff Attorney

    Re:
    Hanryu
    Holdings, Inc.

Amendment No. 4 to Registration
Statement on Form S-1

Filed March 21, 2023

File No. 333-269419

Dear Mr. Kim:

Hanryu Holdings, Inc.
(the “Company”) confirms receipt of the letter dated March 29, 2023, from the staff (the “Staff”)
of the Securities and Exchange Commission (the “Commission”) with respect to the above-referenced filing. We are responding
to the Staff’s comments as set forth below. The Staff’s comments are set forth below, followed by the Company’s response
in bold:

Amendment No. 5 to Registration Statement
on Form S-1 (the “Registration Statement”)

Management's Discussion
and Analysis of Financial Condition and Results of Operations Results of Operations

Revenue, page 62

1. Please
                                            revise to indicate the correct revenue amount in your discussion for the year ended December
                                            31, 2021 of $480,224, not $408,821.

RESPONSE:
In response to the Staff’s comment, the Company has updated the discussion on page 62 of the Registration Statement to reflect
the correct revenue amount of $480,224 for the year ended December 31, 2021.

Consolidated Balance Sheets,
page F-4

2. Please
                                            revise to reflect the amount associated with the common stock outstanding as of December
                                            31, 2021 on the appropriate line.

RESPONSE: In
response to the Staff’s comment, the Company has revised the balance sheet on page F-4 of the Registration Statement to reflect
the amount associated with the common stock outstanding as of December 31, 2021.

Notes to Consolidated Financial
Statements

Note 15 - Significant Non-Cash
Transaction, page F-39

3. You
                                            disclose here that for the year ended December 31, 2022, investments of $1,578,158 were reduced
                                            by receiving non-trade receivables for the same aggregate value. Based on your disclosures
                                            in Note 9, it appears that the only investments sold during fiscal 2022 were the Setopia
                                            Bonds from which you received cash consideration of $696,621 and a non-trade receivable
                                            for $867,987. Please explain what investment sale the $710,171 non- trade receivable relates
                                            to and revise your disclosures in Note 9 (and elsewhere as necessary) to include a discussion
                                            of such transaction.

RESPONSE:
In response to the Staff’s comment, the Company has updated its disclosures on page F-32 of the Registration Statement to include
a discussion of the transaction that resulted in the $710,171 non-trade receivable.

We trust that this response
satisfactorily responds to your request. Should you require further information, please contact our legal counsel Matthew Ogurick at
(212) 536-4085.

    Very truly yours,

    /s/ Chang-Hyuk
    Kang

    Chang-Hyuk Kang,

    Chief Executive Officer

cc: Matthew Ogurick, Esq. of K&L Gates
LLP